Istradefylline (KW-6002)

DRUG8 trials

Sponsors

Kyowa Kirin Co., Ltd., Kyowa Kirin, Inc.

Conditions

Movement Disorder SyndromeParkinson's DiseaseRestless Legs SyndromeSleep Disorder

Phase 2

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

CompletedNCT00199355

Kyowa Kirin Co., Ltd.Parkinson's Disease

Start: 2005-04-30End: 2006-03-31Target: 75Updated: 2014-05-23

Study of Istradefylline (KW-6002) for the Treatment of Restless Legs Syndrome

CompletedNCT00199446

Kyowa Kirin, Inc.Restless Legs Syndrome, Sleep Disorder

Start: 2005-07-31End: 2006-10-31Target: 160Updated: 2024-04-25

A Study of Istradefylline (KW-6002) as Monotherapy in Parkinson's Disease (PD) Patients

CompletedNCT00199433

Kyowa Kirin, Inc.Movement Disorder Syndrome, Parkinson's Disease

Start: 2005-05-31End: 2006-08-31Target: 160Updated: 2024-04-25

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

CompletedNCT00250393

Kyowa Kirin Co., Ltd.Parkinson's Disease

Start: 2005-11-30End: 2006-10-31Target: 64Updated: 2012-08-29

12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

CompletedNCT00456794

Kyowa Kirin, Inc.Parkinson's Disease

Start: 2002-03-31End: 2003-10-31Target: 325Updated: 2024-04-25

Phase 3

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

CompletedNCT00199407

Kyowa Kirin, Inc.Parkinson's Disease

Start: 2004-06-30End: 2006-01-31Target: 230Updated: 2024-04-25

A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

CompletedNCT00199394

Kyowa Kirin Co., Ltd.Parkinson's Disease

Start: 2004-11-30End: 2005-11-30Target: 405Updated: 2024-04-25

A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa

CompletedNCT00199420

Kyowa Kirin, Inc.Parkinson's Disease

Start: 2004-07-31End: 2005-12-31Target: 580Updated: 2024-04-25